Twist Bioscience Corporation (TWST) Business Metric Overview - Stocknear

Twist Bioscience Corporat...

NASDAQ: TWST · Real-Time Price · USD
25.77
0.14 (0.55%)
At close: Sep 05, 2025, 3:59 PM
25.84
0.28%
After-hours: Sep 05, 2025, 07:13 PM EDT

Twist Bioscience Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018
Antibody Discovery Revenue 5.61M 5.7M 5.7M 5.3M 5.1M 4.7M 5.23M 3.39M 4.58M 7.03M 8.17M 6.53M 6.24M 6.59M 4.81M 4.1M 3.14M 3.22M 1.51M 1.2M 1M 1.1M 1.24M 1.31M 1.21M 1.26M 810K
Antibody Discovery Revenue Growth -1.46% -0.02% +7.53% +3.86% +8.53% -10.05% +54.30% -26.05% -34.89% -13.92% +25.17% +4.58% -5.24% +36.86% +17.50% +30.45% -2.58% +113.44% +26.04% +19.32% -8.81% -11.35% -5.48% +8.24% -3.34% +55.06% n/a
Dna And Biopharma Libraries Revenue 2.06M 3.02M 2.79M 3.62M 3.85M 3.53M 2.94M 2.66M 2.88M 2.83M 1.84M 1.5M 1.42M 1.97M 1.26M 21.45M 18.7M 16.95M 8.87M 8.64M 9.6M 9.12M 7.84M 7.86M 6.24M 6.1M 6.51M
Dna And Biopharma Libraries Revenue Growth -31.85% +7.98% -22.71% -6.06% +8.98% +20.14% +10.53% -7.67% +1.91% +53.92% +22.48% +5.41% -27.71% +55.99% -94.12% +14.71% +10.30% +91.02% +2.76% -10.08% +5.35% +16.33% -0.33% +25.95% +2.36% -6.34% n/a
Ngs Tools Revenue 55.28M 51.15M 48.64M 45.54M 43.4M 40.77M 39.42M 37.11M 33.24M 28.99M 24.36M 29.19M 27.79M 23.1M 19.23M 2.67M 2.02M 1.84M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Ngs Tools Revenue Growth +8.09% +5.15% +6.82% +4.92% +6.44% +3.44% +6.23% +11.62% +14.65% +19.01% -16.54% +5.03% +20.29% +20.13% +619.72% +32.47% +9.56% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Oligo Pools Revenue 5.42M 4.71M 5.09M 4.61M 4.17M 3.94M 4.19M 3.74M 3.73M 3.31M 3.7M 3.67M 3.26M 2.31M 3.19M 9.74M 11.16M 9.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Oligo Pools Revenue Growth +15.11% -7.52% +10.47% +10.68% +5.74% -5.94% +12.01% +0.13% +12.67% -10.38% +0.82% +12.58% +41.20% -27.60% -67.26% -12.79% +21.49% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Synthetic Genes Revenue 27.68M 28.22M 26.48M 25.65M 24.95M 22.36M 19.73M 20.05M 19.3M 18.01M 16.18M 16.42M 17.4M 14.16M 13.53M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Synthetic Genes Revenue Growth -1.92% +6.56% +3.26% +2.81% +11.59% +13.33% -1.63% +3.89% +7.17% +11.35% -1.50% -5.63% +22.86% +4.72% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018
Americas Revenue 59.39M 55.19M 53.71M 52.66M 51.39M 45.87M 43.96M 43.68M 39.02M 34.92M 33.65M 34.84M 35.8M 28.46M 22.61M 76.58M 544K 484K 302K 290K 269K 369K 1.24M 744K 527K 211K 420K
Americas Revenue Growth +7.61% +2.76% +1.99% +2.48% +12.02% +4.35% +0.65% +11.94% +11.71% +3.80% -3.42% -2.68% +25.79% +25.86% -70.47% +13977.02% +12.40% +60.26% +4.14% +7.81% -27.10% -70.27% +66.80% +41.18% +149.76% -49.76% n/a
Asia Pacific Revenue 5.93M 6.96M 6.7M 6.54M 6.49M 7.17M 6.32M 6.06M 5.66M 6.47M 4.27M 5.6M 4.83M 4.46M 4.04M 2.77M 3.1M 2.67M 1.77M 1.75M 1.18M 944K 5.94M 5.43M 878K 719K 2.44M
Asia Pacific Revenue Growth -14.85% +3.91% +2.38% +0.77% -9.38% +13.40% +4.26% +7.18% -12.66% +51.78% -23.79% +15.80% +8.26% +10.47% +45.82% -10.47% +16.17% +50.82% +0.91% +48.52% +24.89% -84.11% +9.31% +519.02% +22.11% -70.47% n/a
Emea Revenue 30.74M 30.64M 28.3M 25.5M 23.58M 22.26M 21.22M 17.21M 19.07M 18.78M 16.33M 16.87M 15.48M 15.2M n/a n/a n/a n/a 9.06M 7.25M 6.39M 6.23M n/a n/a 3.51M 3.31M n/a
Emea Revenue Growth +0.33% +8.26% +10.98% +8.15% +5.92% +4.92% +23.31% -9.75% +1.54% +15.00% -3.20% +8.97% +1.83% n/a n/a n/a n/a n/a +24.85% +13.47% +2.60% n/a n/a n/a +5.85% n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017
Selling, General, and Administrative Revenue 63.37M 63.67M 56.18M 53.14M 56.79M 55.62M 52.84M 47.39M 46.06M 53.97M 42.32M 54.16M 53.69M 54M 51.1M 38.24M 34.48M 34.39M 28.79M 27.18M 22.49M 27.19M 26.41M 24.42M 21.32M 19.12M 15.26M 12.95M 11.26M 9.98M 9.26M 8.41M 5.92M
Selling, General, and Administrative Revenue Growth -0.47% +13.34% +5.71% -6.43% +2.11% +5.26% +11.50% +2.90% -14.65% +27.50% -21.85% +0.87% -0.56% +5.68% +33.61% +10.92% +0.26% +19.44% +5.91% +20.89% -17.30% +2.97% +8.12% +14.55% +11.48% +25.33% +17.80% +15.08% +12.81% +7.72% +10.16% +42.07% n/a
Research and Development Revenue 18.05M 23.92M 21.31M 21.13M 22.47M 24.15M 23.1M 23.75M 24.53M 27.38M 31.24M 29.61M 36.84M 31.23M 22.63M 19.44M 19.84M 15.79M 14M 11.64M 10.44M 10.63M 10.3M 10.5M 9.01M 8.91M 7.27M 6.07M 5.27M 4.71M 4.3M 4.85M 5.28M
Research and Development Revenue Growth -24.54% +12.25% +0.82% -5.94% -6.96% +4.55% -2.72% -3.19% -10.41% -12.36% +5.53% -19.64% +17.96% +38.01% +16.39% -1.99% +25.63% +12.79% +20.32% +11.41% -1.74% +3.22% -1.90% +16.53% +1.12% +22.47% +19.92% +15.13% +11.82% +9.48% -11.30% -8.07% n/a